USPTO trademark

INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ

RegisteredUSPTOWord and designClass 5

"INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ" is a word and design mark owned by Seqirus UK Limited, filed at the USPTO on April 7, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Seqirus UK Limited portfolioGet this data via the API
Official USPTO record
INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ trademark as filed
As filed with the USPTO
Status
Registered
Since May 26, 2026
Filed
April 7, 2025
Registered
May 26, 2026
Priority date
March 28, 2025
Claimed from United Kingdom
Application no.
99124687
Registration no.
8269197
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Seqirus UK Limited

Maidenhead, Berkshire, United Kingdom

674 trademarks in the portfolioView company

Representative

Nancy Sabarra

Fross Zelnick Lehrman & Zissu, P.C.

Goods and services

What the mark covers

The products and services INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Teas/email correspondence entered
  8. Correspondence received in law office
  9. Teas response to office action received
  10. Application extension granted/receipt provided

10 earlier steps on the official record.

FAQ

About INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ

Who owns the trademark "INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ"?

The USPTO trademark "INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ" (application 99124687) is owned by Seqirus UK Limited.

What is the status of "INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ"?

Its status at the USPTO is: registered.

When was "INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ" registered?

It was registered on May 26, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2aa6-2f10-7138-99ed-2bfb8287e77a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2aa6-2f10-7138-99ed-2bfb8287e77a",
  "object": "trademark",
  "mark_text": "INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99124687",
  "filing_date": "2025-04-07",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Seqirus UK Limited",
      "entity_id": "ent_019eb7be-6b9c-74dc-8e1a-a6460bc0e0a9"
    }
  ]
}